<DOC>
	<DOC>NCT00463866</DOC>
	<brief_summary>The purpose of this study is to evaluate the effect of two different maintenance doses of Symbicort Maintenance And Reliever Therapy (SMART) in adult asthmatic patients. A 6 month treatment period</brief_summary>
	<brief_title>Local Phase 4 Pan-European SMART Study</brief_title>
	<detailed_description />
	<mesh_term>Budesonide, Formoterol Fumarate Drug Combination</mesh_term>
	<mesh_term>Formoterol Fumarate</mesh_term>
	<mesh_term>Budesonide</mesh_term>
	<criteria>Patients at outpatient clinics &gt;18 years with a minimum of 6 months documented history of persistent asthma who have used inhaled glucocorticosteroids for at least one month and have a history of use in rapidacting B2 agonists for symptom relief Asthma exacerbation within the last 14 days prior to study start subject aged &gt;40 years with a smoking history of &gt;10packyears subjects with chronic obstructive lung disease or other significant respiratory disease</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2010</verification_date>
	<keyword>Asthma</keyword>
</DOC>